Dishman Carbogen Amcis Limited reported earnings results for the second quarter and six months ended September 30, 2025. For the second quarter, the company reported sales was INR 6,526.5 million compared to INR 7,890.4 million a year ago. Revenue was INR 6,607.6 million compared to INR 7,956.9 million a year ago. Net income was INR 652.7 million compared to INR 330.9 million a year ago. Basic earnings per share from continuing operations was INR 4.16 compared to INR 2.11 a year ago. Diluted earnings per share from continuing operations was INR 4.16 compared to INR 2.11 a year ago.
For the six months, sales was INR 13,607 million compared to INR 13,128.2 million a year ago. Revenue was INR 13,935.6 million compared to INR 13,209 million a year ago. Net income was INR 886.8 million compared to net loss of INR 444.8 million a year ago. Basic earnings per share from continuing operations was INR 5.66 compared to basic loss per share from continuing operations of INR 2.84 a year ago. Diluted earnings per share from continuing operations was INR 5.66 compared to diluted loss per share from continuing operations of INR 2.84 a year ago.
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Companyâs segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.
